Photo above: On Friday, March 8, 2024, representatives from Nusano and The Wasatch Group cut the ribbon on the...
![Nusano Opens Radiochemistry Laboratory to Advance Isotope Commercialization and Customer Collaboration](https://nusano.com/wp-content/uploads/2024/03/Nusano-Radiance-Lab-Ribbon-Cutting-1080x675.jpg)
Photo above: On Friday, March 8, 2024, representatives from Nusano and The Wasatch Group cut the ribbon on the...
VALENCIA, Calif. – February 26, 2024 – Nusano, a physics company transforming the production of medical radioisotopes,...
VALENCIA, Calif. – Jan. 22, 2024 – Nusano, a physics company transforming the production of medical radioisotopes,...
EVENT REPLAY NOW AVAILABLE Recorded December 19, 2023Press release updated December 14, 2023 to include addition of...
Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced that senior management will participate in the following investor conferences in October.
Nusano, Inc. has appointed pharmaceutical executive Alexandre Gibim as the company’s Chief Operations Officer (COO). Gibim will be responsible for enabling and scaling Nusano’s business functions to create a reliable domestic and global supply of medical radioisotopes, the active pharmaceutical ingredients (APIs) at the core of next-generation cancer therapeutics.
Sign up to receive company news and updates